CompaniesCirce Biomedical

Circe Biomedical

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

40

By Phase

NA: 3

By Status

COMPLETED: 2TERMINATED: 1

Recent Trials

NCT04591925Lead Sponsor
SteadiSet™ Pilot Study (SteP Study)
NATerminated
13 participants
Started: Feb 5, 2021 · Completed: Nov 2, 2021
NCT04398030Lead Sponsor
"Pharmacokinetics (PK)/ Pharmacodynamics (PD) of an Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Patients (PEXIS)"
NACompleted
7 participants
Started: Jul 17, 2020 · Completed: Apr 22, 2021
NCT04503564Lead Sponsor
"FEXIS: (Feasibility of an Extended Wear CSII Set in Participants With T1DM)"
NACompleted
20 participants
Started: Nov 13, 2019 · Completed: Nov 11, 2020
Funding History (1)
S-1
Jun 20, 1997
Filing
Related Companies
Icn Pharmaceuticals
acquired